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erobic Training Decreases
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OBJECTIVES We sought to evaluate the effect of physical training on neurohormonal activation in patients
with heart failure (HF).
BACKGROUND Patients with HF benefit from physical training. Chronic neurohormonal activation has
detrimental effects on ventricular remodeling and prognosis of patients with HF.
METHODS A total of 95 patients with HF were assigned randomly into two groups: 47 patients (group
T) underwent a nine-month training program at 60% of the maximal oxygen uptake (VO2),
whereas 48 patients did not (group C). The exercise load was adjusted during follow-up to
achieve a progressive training effect. Plasma assay of B-type natriuretic peptide (BNP),
amino-terminal pro-brain natriuretic peptide (NT-proBNP), norepinephrine, plasma renin
activity, and aldosterone; quality-of-life questionnaire; echocardiogram; and cardiopulmonary
stress test were performed upon enrollment and at the third and ninth month.
RESULTS A total of 85 patients completed the protocol (44 in group T, left ventricular ejection fraction
[EF] 35  2%, mean  SEM; and 41 in group C, EF 32  2%, p  NS). At the ninth
month, patients who underwent training showed an improvement in workload (14%, p 
0.001), peak VO2 (13%, p  0.001), systolic function (EF 9%, p  0.01), and quality of
life. We noted that BNP, NT-proBNP, and norepinephrine values decreased after training
(34%, p 0.01;32%, p 0.05;26%, p 0.01, respectively). Increase in peak VO2 with
training correlated significantly with the decrease in both BNP/NT-proBNP level (p 0.001
and p  0.01, respectively). Patients who did not undergo training showed no changes.
CONCLUSIONS Clinical benefits after physical training in patients with HF are associated with blunting of
adrenergic overactivity and of natriuretic peptide overexpression. (J Am Coll Cardiol 2006;




















phronic heart failure (HF) is characterized by fatigue,
yspnea, abnormal peak oxygen uptake (peak VO2), and
entilatory efficiency to exercise measured by the slope of
ncrease in ventilation over carbon dioxide output (VE/VCO2
lope) (1). Despite pharmacologic therapy, the prognosis is
oor. Aerobic physical training is known to improve exercise
olerance (2–5), ventilatory efficiency (5), quality of life
QOL) (4), and to counteract sympathetic overactivation
3). Finally, rates of mortality and hospitalization decrease
fter patients undergo training independently from medical
reatment (6).
Neurohormonal activation is a hallmark of HF (7). The
roduction of B-type natriuretic peptide (BNP) by ventric-
lar cardiomyocytes correlates with left ventricular dysfunc-
ion (8,9). Thus, the assay of either BNP or amino-terminal
ro-brain natriuretic peptide (NT-proBNP) has been pro-
osed as diagnostic and prognostic tool (9). However,
tudies concerning the influence of training on BNP secre-
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005, accepted December 13, 2005.ion early after myocardial infarction (10) and in patients
ith chronic HF (11,12) have given conflicting results. In
his study, we evaluated the effect of home-based aerobic
hysical training, with adjustment of the exercise load
uring follow-up for achieving a progressive training effect,
n neurohormonal activation in patients in HF.
ETHODS
ubjects. We screened 158 consecutive patients with HF
rom 2002 to 2004. Inclusion criteria were impaired left
entricular systolic function (ejection fraction [EF] 45%)
nd exercise capacity (peak VO2 25 ml/min/kg). Exclu-
ion criteria were New York Heart Association (NYHA)
unctional class IV, myocardial infarction or unstable angina
ithin six months before the examination, exercise-limiting
iseases, and severe pulmonary or renal disease. Of the 158
atients, 35 did not match these criteria, whereas 28 refused
o sign the informed consent approved by the institutional
thical committee. Ultimately, 95 patients (80 men and 15
omen, mean age 60  1 years) were enrolled. All 95
atients were on stable (i.e., 1 month) optimal pharma-
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Neurohormones and Physical Training May 2, 2006:1835–9ent or hospitalization resulted in withdrawal from the
tudy.
tudy design. This was a prospective, randomized, con-
rolled study. Patients were assigned randomly into two groups.
he training group (group T) underwent a nine-month train-
ng program, whereas control patients (group C) continued
heir usual lifestyle. The two groups did not differ as to age,
ender, NYHA functional class, EF, pharmacologic treatment,
r HF etiology (Table 1).
Patients underwent neurohormonal and clinical evalua-
ion and a maximal exercise test with gas exchange (cardio-
ulmonary stress test [CPT]) within the same morning
pon enrollment and at the third and ninth month. An
chocardiographic study was performed, and patients rated
heir QOL on entry and at the end of the study.
hysical training. The training program consisted of cy-
ling on a bike for a minimum of 3 days per week, 30 min
er day. Patients were instructed to exercise at 60 rpm,
eeping heart rate constantly monitored at 65% of peak VO2
eart rate, by a wearable device. At the enrollment, they
able 1. Baseline Characteristics of the Study Patients Assigned





ge (yrs) 60  2 61  2
ales/females (n) 39/5 35/6
MI (kg/m2) 25.8  0.3 25.1  0.8
diopathic/postischemic (n) 17/27 18/23
VEF (%) 35.3  1.6 32.3  2.2
inus rhythm/AF (n) 41/3 39/2
YHA functional class
I/II/III
(n  mean  SEM)




ACE inhibitor 78 79
ARB 7 5
Spironolactone 35 38
o significant differences were found for any of the comparisons.
ACE  angiotensinogen-converting enzyme; AF  atrial fibrillation; ARB 
ngiotensin receptor blocker; BMI  body mass index; Group C  control group;
Abbreviations and Acronyms
BNP  B-type natriuretic peptide
CPT  cardiopulmonary stress test
EF  ejection fraction
HF  heart failure
NT-proBNP  amino-terminal pro-brain natriuretic
peptide
NYHA  New York Heart Association
QOL  quality of life
VE/VCO2  ventilation/carbon dioxide production
ratio
VO2  oxygen uptakef
roup T training group; LVEF left ventricular ejection fraction; NYHANew
ork Heart Association.articipated to in-hospital training sessions. Their compli-
nce to the program was checked by a physiotherapist and at
he first, second, third, sixth, and ninth month. At the
hird-month visit, workload was adjusted according to a
ew CPT. Patients in group C underwent follow-up visits
t the third and ninth month to exclude changes in their
sual lifestyle and physical activity.
ardiopulmonary exercise test, echocardiographic study,
OL, and plasma assays. A CPT was performed by
xercise on a bicycle ergometer using a ramp protocol with
ncrements of 10 W/min. We measured VO2, CO2 produc-
ion, and minute ventilation using breath-to-breath gas
nalysis (Vmax, Sensormedics, Conshohocken, Pennsylva-
ia). Peak VO2 (the highest value at end-exercise, as a 20-s
verage) and ventilatory efficiency on exercise (slope of the
entilation vs. VCO2 relation in its linear part) were deter-
ined. The same physician performed all the CPTs and was
naware of the results of blood sampling. The echocardio-
raphic studies were all performed by the same physician.
Quality of life was evaluated by means of the Minnesota
iving With Heart Failure Questionnaire; BNP, plasma
atecholamines, plasma renin activity, and aldosterone
ere assayed as described elsewhere (9); and NT-proBNP
as measured with an automated electrochemiluminescent
mmunoassay.
tatistics. Because neurohormone values are not distrib-
ted normally, natural logarithmic transformation of data
as used for parametric statistical analysis, including two-
ay repeated-measure analysis of variance, Bonferroni post-
oc test, and linear regression analysis. Skewness and Kurtosis
ests were used to determine whether data were normally
istributed. Chi-square and unpaired t tests were used to
valuate differences between the two groups. Mauchly’s test to
ssess the sphericity assumption was performed. To assess
he significance of the interaction between groups, we
pplied the Greenhouse-Geisser correction factor when
auchly’s test was significant (13). The results are ex-
ressed as mean values  SEM, and p values were consid-
red significant when  0.05.
ESULTS
hree patients in group T did not complete the program:
ne required treatment changes, one refused to continue
fter the first month, and one withdrew a after three weeks
ecause of a stroke. Conversely, seven patients in group C
id not complete the program: two were lost at follow-up;
wo required hospitalization for decompensation; two needed
reatment changes; and one withdrew after a diagnosis of
ung cancer. A total of 85 patients completed the protocol
44 in group T, 41 in group C); of these, 5 patients (2 in
roup T and 3 in group C), included in data analysis,
equired only minimal treatment adjustments (change of
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xpected, patients from both group T and C showed
eurohormonal activation, depressed functional capacity,
nd a slightly reduced ventilatory efficiency, with no differ-
nt baseline values (Tables 1 and 2).
Significant relations were found among exercise variables
nd neurohormone plasma levels in both groups, for in-
tance, in group T, peak VO2 was inversely correlated with
igure 1. Changes in exercise variables, resting heart rate, and neurohormo
hree, and nine months. *p  0.05, **p  0.01, ***p  0.001 versus basel




Ejection fraction (%) 35  2
LV-EDVi (ml/m2) 111  8
LV-ESVi (ml/m2) 72  6
Peak VO2 (ml/min/kg) 15  1
Workload (W) 99  6
VE/VCO2 slope 34  1
BNP (ng/l) 187  29
NT-proBNP (ng/l) 1,370  234
Norepinephrine (ng/l) 607  55
PRA (ng/ml/h) 3.04  0.66
Aldosterone (ng/l) 198  27
*p  0.05 vs. group T, †p  0.001 vs. group T, ‡p  0.05, §
BNP  B-type natriuretic peptide; EDVi  end-diasto
volume normalized by body surface area; LV  left ventricula
plasma renin activity; VE  ventilation; VCO2  carbon dioxidroups); #p  0.05, ##p  0.01 versus third month. BNP  brain natriuretic
atriuretic peptide; VO2  oxygen uptake.NP (R  0.55, p  0.001), NT-proBNP (R  0.55, p 
.001), and norepinephrine (R  0.43, p  0.001), whereas
E/VCO2 slope directly correlated with BNP (R 0.61, p
.001), NT-proBNP (R  0.54, p  0.001), and norepi-
ephrine (R  0.43, p  0.001).
ffects of physical training on left ventricular volumes
nd function, functional capacity, and QOL. In group T,
F had increased by the nine-month visit, with a reduction
r trained (open circles) and untrained patients (closed circles) at baseline,
ignificant values assessed by Bonferroni post-hoc test performed on three
hormonal Profile at Baseline and at End
Group C
Month Baseline Ninth Month
 2§ 32  2 31  2†
 6‡ 116  7 120  8†
 5‡ 78  6 80  7†
 1 14  1 13  1†
 6 85  6 80  5†
 1 36  1 37  1*
 23§ 188  27 201  32†
 206‡ 1,581  251 1,677  291†
 39§ 515  34 609  67†
 0.62 4.26  1.21 2.45  0.56
 24 195  26 216  25
01 vs. respective baseline, p  0.001 vs. respective baseline.
me normalized by body surface area; ESVi  end-systolic
proBNP  N-terminal probrain natriuretic peptide; PRA 
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Table 2). Conversely, echocardiographic parameters did
ot change in group C.
Group T progressively increased tolerance to effort from
aseline up to the third and the ninth month (peak VO2 F
0.35, p  0.001, and maximum workload F  13.26, p 
.001) (Fig. 1). Resting heart rate decreased by the end of
he follow-up from 75  2 beats/min to 69  2 beats/min
p  0.002). No changes were found in these parameters in
roup C (Fig. 1). By the end of follow-up, VE/VCO2 slope
id not change in either of the two groups, and only patients
n group T showed an improvement in their QOL (score
rom 54  5 to 32  4 in group T, p  0.01; from 52 
to 53  5 in group C, p  NS).
ffects of physical training on BNP and neurohormones.
uring the follow-up, BNP, NT-proBNP, and norepi-
ephrine progressively decreased in group T (F 7.49, p
.01; F  4.84, p  0.01; and F  9.88, p  0.001,
espectively) but not in group C (Fig. 1). No changes were
ound in either group with respect to plasma renin activity
nd aldosterone. At the end of the program, peak VO2 in
roup T inversely correlated to BNP (R 0.52, p 0.001),
T-proBNP (R  0.51, p  0.001), and norepinephrine
evels (R 0.49, p 0.001) at a similar extent, as compared
ith baseline. A similar correlation was found between
E/VCO2 slope and the levels of BNP (R  0.61, p 
.001), NT-proBNP (R  0.60, p  0.001), and norepi-
ephrine (R  0.59, p  0.001). The change in peak VO2
t the end of the program was correlated with BNP and
T-proBNP changes (R  0.42, p  0.001 and R  0.31,
 0.01, respectively), but not with norepinephrine
hanges (Fig. 2). Conversely, no correlation was found
etween the decrease in BNP, NT-proBNP, and norepi-
ephrine values and the absolute 3% increase in EF in group
. Finally, a relationship was found between the change in
ither BNP or NT-proBNP level and the norepinephrine
hange (R 0.46, p  0.002 and R 0.36, p  0.02,
espectively).
ISCUSSION
he present study demonstrates that progressively adjusted
igure 2. Relation between the changes in peak oxygen uptake (VO2) and
patients. BNP  brain natriuretic peptide.erobic physical training on a nine-month period progres- qively improves functional capacity, QOL, as well as left
entricular function in patients with HF. These beneficial
hanges are associated with reduction in plasma levels of
NP/NT-proBNP and norepinephrine. Hence, BNP/NT-
roBNP plasma concentration appears to be a valuable
arker of positive clinical response to training.
Previous studies have demonstrated that training im-
roves cardiac function, peak oxygen uptake, and QOL
2–6,11,12). However, long-term training programs per-
ormed with a constant intensity of exercise do not seem to
uarantee a continuous improvement in functional capacity
4). Conversely, a workload adjusted according to the third-
onth CPT produced a progressive increase in peak VO2,
aralleled by a progressive decrease in neurohormone level
n the present study.
The lack of improvement of the VE/VCO2 slope could be
scribed to the quite-preserved exercise capacity and venti-
atory efficiency in our population (Table 2) as compared
ith a previous study (14). The reduction in plasma BNP/
T-proBNP in group T might be an expression of im-
roved cardiac systolic function (8), sympathetic deactiva-
ion (12), and improvement in tissue oxygenation (15). The
ecrease in plasma norepinephrine level might be explained
y the positive modulation of the autonomic balance by
hysical training (3).
tudy limitations. A control group of healthy subjects was
ot included because it is unlikely that training could affect
heir BNP/NT-proBNP plasma levels under physiologic
onditions (8). Furthermore, women accounted for only
5% of the patients, a figure which reflects the female
revalence of larger HF studies, among which the Extra-
ATCH meta-analysis on training in HF (6).
onclusions. The BNP/NT-proBNP and norepinephrine
lasma values progressively decrease after training, parallel-
ng functional and clinical improvement. The present find-
ngs suggest the usefulness of the BNP/NT-proBNP assay
s an effective tool for the follow-up of patients with HF
ndergoing physical training.
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